TGF-β1 signalling was essential for cardiac fibrosis, and blocking TGF-β1 effectively reversed CFs transdifferentiation and reduced ECM deposition, which might be the therapeutic target for myocardial fibrosis 26. Here, TGFB1 is linked to Myocardial fibrosis.